The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice

Linlin Bao; Qiang Wei; Pin Yü; Yanfeng Xu; Feifei Qi; Yajin Qu; Fengdi Li; Guanpeng Wang; Shunyi Wang; Zhiqi Song; Linna Zhao; Peipei Liu; Li Zhao; Fei Ye; Huijuan Wang; Weimin Zhou; Na Zhu; Zhen Wei; Haisheng Yu; Xiaojuan Zhang; Li Guo; Lan Chen; Conghui Wang; Ying Wang; Xinming Wang; Guizhen Wu; Chuan Qin; Wei Deng; Baoying Huang; Hong Gao; Jiangning Liu; Lili Ren; Qi Lv; Wen‐Ching Wang; Jing Xue; Shuran Gong; Mingya Liu; Yan Xiao; Qiangming Sun; Hongqi Liu; Fanli Zhu; Chunxia Ma; Lingmei Yan; Mengli Yang; Jun Han; Wenbo Xu; Wenjie Tan; Xiaozhong Peng; Qi Jin

doi:10.1038/s41586-020-2312-y

Keywords

VirusVirologyCoronavirusViral replicationBiologyPathogenesisGenetically modified mouseImmunologyTransgeneDiffuse alveolar damageLungCoronavirus disease 2019 (COVID-19)MedicinePathologyDiseaseInfectious disease (medical specialty)GeneInternal medicine

Affiliated Institutions

Related Publications

SARS-CoV-2 Reverse Genetics Reveals a Variable Infection Gradient in the Respiratory Tract

Yixuan J. Hou , Kenichi Okuda , Caitlin E. Edwards +40 more

The mode of acquisition and causes for the variable clinical spectrum of coronavirus disease 2019 (COVID-19) remain unknown. We utilized a reverse genetics system to generate a ...

2020 Cell 1608 citations

NVX-CoV2373 vaccine protects cynomolgus macaque upper and lower airways against SARS-CoV-2 challenge

Mimi Guebre‐Xabier , Nita Patel , Jing-Hui Tian +10 more

There is an urgent need for a safe and protective vaccine to control the global spread of SARS-CoV-2 and prevent COVID-19. Here, we report the immunogenicity and protective effi...

2020 Vaccine 238 citations

Coronaviruses post-SARS: update on replication and pathogenesis

Stanley Perlman , Jason Netland

Although coronaviruses were first identified nearly 60 years ago, they only received notoriety in 2003 when one of their members was identified as the aetiological agent of seve...

2009 Nature Reviews Microbiology 1795 citations

Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection

Jacqueline Cronin , Robert Jordan , Atsushi Okumura +6 more

The continued emergence of Middle East Respiratory Syndrome (MERS) cases with a high case fatality rate stresses the need for the availability of effective antiviral treatments....

2020 Proceedings of the National Academy o... 927 citations

An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice

Timothy P. Sheahan , Amy Sims , Shuntai Zhou +25 more

A ribonucleoside analog inhibits SARS-CoV-2 in human airway epithelial cell cultures and SARS-CoV and MERS-CoV in mice.

2020 Science Translational Medicine 1132 citations

Publication Info

Year: 2020
Type: article
Volume: 583
Issue: 7818
Pages: 830-833
Citations: 1208
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

1208

OpenAlex

Cite This

APA Style

                            
                                
                                    Linlin Bao, 
                                
                                    Qiang Wei, 
                                
                                    Pin Yü
                                
                                et al.
                            
                            (2020). 
                            The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice. 
                            Nature
                            , 583
                            (7818)
                            , 830-833.
                            https://doi.org/10.1038/s41586-020-2312-y
                        

Identifiers

DOI: 10.1038/s41586-020-2312-y